Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis-Reference-Cited by-同舟云学术

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

Published:2016-05-09 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wang Yongjun¹,Parker Claire E²,Feagan Brian G²³⁴,MacDonald John K²³

Affiliation:

1. University of Western Ontario; Schulich School of Medicine & Dentistry; London ON Canada

2. Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6

3. University of Western Ontario; Department of Medicine; London ON Canada

4. University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference160 articles.

1. 5-aminosalicylic acid (5-ASA) versus salazopirin (SASP) in the oral treatment of active ulcerative colitis (UC) and in remission [abstract];Andreoli;Clinical Controversies in Inflammatory Bowel Disease,1987

2. Coated oral 50 aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis;Ardizzone;Journal of Clinical Gastroenterology,1995

3. Comparison of mesalazine with sulphasalazine in prophylactic treatment of ulcerative collitis [abstract];Bianchi Porro;Gut,1989

4. Is maintenance therapy always necessary for patients with ulcerative colitis?;Ardizzone;Alimentary Pharmacology and Therapeutics,1999

5. Prospective randomized trial of mesalazine versus olsalazine in ulcerative colitis;Courtney;Gastroenterology,1990

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14

2. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

3. Oral carbon dot nanozymes with red fluorescence and superoxide dismutase-like activity for colitis bioimaging and inflammation management;Chemical Engineering Journal;2024-08

4. Pharmacogenetics in personalized treatment in pediatric patients with inflammatory bowel disease (IBD);Česko-slovenská pediatrie;2024-08-01

5. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31